SOURCE: Media Analytics Corporation

September 16, 2013 08:15 ET

Fansport Inc. Changes Name to Media Analytics Corporation

HONG KONG, CHINA--(Marketwired - Sep 16, 2013) - On September 3, 2013, Media Analytics Corporation (OTCBB: MEDA) (OTCQB: MEDA) (the "Company") changed its name from Fansport, Inc. to Media Analytics Corporation pursuant to approval from its board of directors and a majority of its stockholders. An Amendment to the Articles of Incorporation was filed with the Florida Secretary of State on August 28, 2013, with an effective date of September 3, 2013.

The name change is part of a larger rebranding effort to emphasize the Company's commitment to social media analytics technology solutions for brand marketers, advertisers and publishers.

"The name Media Analytics underscores the Company's emphasis on social media tracking solutions and technology expertise," said Stephen Wong, president of the Company. "Our goal is to expand our influence throughout the U.S. and Europe, meeting the demand for analytical tools to address a rapidly expanding market."

For further details on the corporate name change, please see the Company's Form 8-K: http://www.sec.gov/Archives/edgar/data/1518171/000116169713000623/form_8-k.htm.

About Media Analytics Corporation

Media Analytics Corporation's social media tools and solutions enable advertisers, publishers and agencies in the U.S. and U.K. markets to gather deep social intelligence, generate true engagement and simplify promotional management. The company's current offering, Klarity, is the most comprehensive and robust social analytics dashboard available. Klarity provides detailed comparative metrics from the widest range of social platforms, and provides the added uniqueness for Western marketers to gain insights into the social behavior of Asian consumers.

www.media-analytics.us

Safe Harbor Statement

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned and should consult all of the information set forth herein, that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and specifically statements relating to growth of the Company. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the marketing of the Company's product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company's ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.

Contact Information